Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Management in Autologous Blood Collection for CABG
NCT06835257Phase 4Completed
- Sponsor
- Atatürk University
- Start
- Jun 2022
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary artery disease (CAD) (2 arms), sponsored by Atatürk University. Primary endpoint: Cardiac Cycle Efficiency at 30 minutes. Started Jun 2022; status: completed.
02
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT06835257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06835257.